newsfilter
← Latest News
GlobeNewswire·

Aravive to Host Virtual KOL Event on its Late-Stage Oncology Asset Batiraxcept

HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV, "the Company")), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced it will host a